Phosphotyrosine phosphatase activity and haematologic changes in Down's syndrome patients.
Assays of neutrophil phosphotyrosine phosphatase activity and determination of haematological parameters were performed on 12 trisomic 21 probands without any clinical or biological symptom of other evolutive disease. Haematological studies showed the two main classical abnormalities: the existence of a macrocytosis and an enhanced lymphocyte count. Of interest are the very reduced rates of phosphotyrosine phosphatase activity found in granulocytes from these patients. This defect in protein phosphatase can be considered as an additional enzymatic change extending the list of modified factors recognized at molecular and cellular levels in subjects whose risk of leukaemia is significantly increased.
Vergnes
H
H
Laboratoire d'Enzymologie, INSERM, CNRS, CHU de Rangueil, Toulouse, France.
Brisson-Lougarre
A
A
Limouzy
P
P
Dray
C
C
Grozdea
J
J
D000293:Adolescent; D000328:Adult; D001772:Blood Cell Count; D004314:Down Syndrome / Q000097:blood* / Q000201:enzymology*; D004912:Erythrocytes / Q000473:pathology; D005260:Female; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007958:Leukocyte Count; D008297:Male; D009504:Neutrophils / Q000201:enzymology; D017027:Protein Tyrosine Phosphatases / Q000097:blood*
D006454:Hemoglobins; D017027:Protein Tyrosine Phosphatases